Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
4,458,508
-
Shares change
-
-23,351
-
Total reported value, excl. options
-
$22,959,000
-
Value change
-
-$197,277
-
Number of buys
-
6
-
Number of sells
-
-9
-
Price
-
$5.15
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q4 2019
27 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q4 2019.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,458,508 shares
of 14,965,850 outstanding shares and own 30% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (1,010,220 shares), Stonepine Capital Management, LLC (896,170 shares), DIMENSIONAL FUND ADVISORS LP (860,319 shares), RENAISSANCE TECHNOLOGIES LLC (469,338 shares), VANGUARD GROUP INC (391,695 shares), BlackRock Inc. (331,559 shares), BRIDGEWAY CAPITAL MANAGEMENT INC (183,000 shares), ACADIAN ASSET MANAGEMENT LLC (98,192 shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (53,800 shares), and GEODE CAPITAL MANAGEMENT, LLC (48,610 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.